SEC Form 4 · accession 0001651844-16-000018
NYMOX PHARMACEUTICAL CORP · NYMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James George Robinson
Director
Period of report
May 10, 2016
Accepted (ET)
May 13, 2016 · 6:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001018735
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 10, 2016 | P | 3,010 | $2.32 | A | 2,782,550 | D | |
| Common Stock | May 11, 2016 | P | 5,000 | $2.29 | A | 2,787,550 | D | |
| Common Stock | May 11, 2016 | P | 2,000 | $2.28 | A | 2,789,550 | D | |
| Common Stock | May 12, 2016 | P | 2,500 | $2.29 | A | 2,792,050 | D | |
| Common Stock | May 12, 2016 | P | 2,500 | $2.32 | A | 2,794,550 | D | |
| Common Stock | May 13, 2016 | P | 2,500 | $2.36 | A | 2,797,050 | D | |
| Common Stock | May 13, 2016 | P | 2,500 | $2.35 | A | 2,799,550 | D | |
| Common Stock | May 13, 2016 | P | 3,000 | $2.33 | A | 2,802,550 | D | |
| Common Stock | May 13, 2016 | P | 5,000 | $2.31 | A | 2,807,550 | D | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust |
Table II — derivative securities
No Table II lines on this filing.